Stress, drugs, and evolution: The role of cellular signaling in fungal drug resistance

被引:215
作者
Cowen, Leah E. [1 ]
Steinbach, William J. [2 ,3 ,4 ]
机构
[1] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
[2] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA
基金
加拿大健康研究院;
关键词
D O I
10.1128/EC.00041-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:747 / 764
页数:18
相关论文
共 243 条
[1]   Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis [J].
Abruzzo, GK ;
Flattery, AM ;
Gill, CJ ;
Kong, L ;
Smith, JG ;
Pikounis, VB ;
Balkovec, JM ;
Bouffard, AF ;
Dropinski, JF ;
Rosen, H ;
Kropp, H ;
Bartizal, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2333-2338
[2]   Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain:: 1994-1996 and 1997-2005 [J].
Aller, A. I. ;
Claro, R. ;
Castro, C. ;
Serrano, C. ;
Colom, M. F. ;
Martin-Mazuelos, E. .
CHEMOTHERAPY, 2007, 53 (04) :300-305
[3]   Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness [J].
Anderson, JB .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (07) :547-556
[4]   Susceptibility of environmental versus clinical strains of pathogenic Aspergillus [J].
Araujo, Ricardo ;
Pina-Vaz, Cidalia ;
Rodrigues, Acacio Goncalves .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (01) :108-111
[5]   Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis [J].
Armengou, A ;
Porcar, C ;
Mascaro, J ;
GarciaBragado, F .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1337-1338
[6]   Anticipating clinical resistance to target-directed agents - The BCR-ABL paradigm [J].
Azam, Mohammad ;
Daley, George Q. .
MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (02) :67-76
[7]   In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance [J].
Bachmann, SP ;
Patterson, TF ;
López-Ribot, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2228-2230
[8]   Sensing the environment: lessons from fungi [J].
Bahn, Yong-Sun ;
Xue, Chaoyang ;
Idnurm, Alexander ;
Rutherford, Julian C. ;
Heitman, Joseph ;
Cardenas, Maria E. .
NATURE REVIEWS MICROBIOLOGY, 2007, 5 (01) :57-69
[9]   A unique fungal two-component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans [J].
Bahn, Yong-Sun ;
Kojima, Kaihei ;
Cox, Gary M. ;
Heitman, Joseph .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (07) :3122-3135
[10]   Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1 [J].
Balashov, Sergey V. ;
Park, Steven ;
Perlin, David S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2058-2063